» Articles » PMID: 4435583

Radioimmunoassay of Cholecystokinin-pancreozymin

Overview
Journal Gut
Specialty Gastroenterology
Date 1974 Sep 1
PMID 4435583
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A sensitive and specific radioimmunoassay for cholecystokinin-pancreozymin (CCK-PZ) has been developed, using rabbit antisera to crude porcine hormone. Highly purified porcine CCK-PZ, labelled with (131)I, and repurified by column chromatography on Sephadex G15, was used as tracer. Separation of free from antibody-bound labelled CCK-PZ was carried out using charcoal, ion-exchange resin, or a double antibody procedure. Non-specific interference with the assay system by serum factors was abolished (as judged by in-vitro and in-vivo recovery studies) by boiling and diluting the serum samples before assay. Ninety-nine per cent pure porcine CCK-PZ (standard), commercial CCK-PZ preparations, caerulein, the C-terminal 8- and 12-amino acid fragments of the CCK-PZ molecule, and endogenous human CCK-PZ all cross reacted in the assay system and showed parallel inhibition curves. No significant cross reaction was found with gastrin, secretin, glucagon, or insulin. The sensitivity of the assay is approximately 5 pg per ml of test solution, which proved adequate for measuring physiological levels of CCK-PZ in peripheral blood in man.The mean immunoreactive CCK-PZ concentration in 50 fasting normal subjects was 60.4 pg per ml. The distribution of individual values was skewed, however, so that the median was much lower (30 pg per ml). Older subjects had higher fasting levels of CCK-PZ than were found in young adults.

Citing Articles

Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers.

Leng G, Sabatier N J Neuroendocrinol. 2016; 28(10).

PMID: 27467712 PMC: 5096068. DOI: 10.1111/jne.12413.


Cholecystokinin metabolism in normal man and patients with duodenal ulcer.

Ramus N Ann R Coll Surg Engl. 1982; 64(6):383-90.

PMID: 7137828 PMC: 2494071.


A radioimmunoassay for cholecystokinin (CCK).

BROOKS F Dig Dis Sci. 1983; 28(5):469.

PMID: 6839909 DOI: 10.1007/BF02430536.


Radioimmunoassay of cholecystokinin.

Chang T, Chey W Dig Dis Sci. 1983; 28(5):456-68.

PMID: 6839908 DOI: 10.1007/BF02430535.


Pathogenesis of the impaired gall bladder contraction of coeliac disease.

Brown A, Bradshaw M, Richardson R, Wheeler J, Harvey R Gut. 1987; 28(11):1426-32.

PMID: 3428667 PMC: 1433691. DOI: 10.1136/gut.28.11.1426.


References
1.
Harvey R, Read A . Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome. Lancet. 1973; 1(7793):1-3. DOI: 10.1016/s0140-6736(73)91219-1. View

2.
ONDETTI M, Pluscec J, SABO E, SHEEHAN J, Williams N . Synthesis of cholecystokinin-pancreozymin. I. The C-terminal dodecapeptide. J Am Chem Soc. 1970; 92(1):195-9. DOI: 10.1021/ja00704a033. View

3.
Rehefeld J . Three components of gastrin in human serum. Gel filtration studies on the molecular size of immunoreactive serum gastrin. Biochim Biophys Acta. 1972; 285(2):364-72. View

4.
ADLERCREUTZ E, Pettersson T, Adlercreutz H, GRIBBE P, WEGELIUS C . Effect of cholecystokinin on duodenal tonus and motility. Acta Med Scand. 1960; 167:339-42. DOI: 10.1111/j.0954-6820.1960.tb03556.x. View

5.
Yalow R, Berson S . Further studies on the nature of immunoreactive gastrin in human plasma. Gastroenterology. 1971; 60(2):203-14. View